Benzinga | Oct 29, 2020 05:05PM EDT

Bio-Rad Laboratories Q3 EPS $3.00 Beats $1.80 Estimate, Sales $647.26M Beat $570.58M Estimate

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $1.80 by 66.67 percent. This is a 86.34 percent increase over earnings of $1.61 per share from the same period last year. The company reported quarterly sales of $647.26 million which beat the analyst consensus estimate of $570.58 million by 13.44 percent. This is a 15.45 percent increase over sales of $560.63 million the same period last year.